Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
MAP Pharmaceuticals, Inc. (MAPP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2013 |
4
| CHAI CHRISTOPHER Y (SVP, CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| KELLEY BERNARD J (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| NELSON TIMOTHY S (President and CEO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| ARMER THOMAS A (Chief Scientific Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| Friedman Charlene A (SVP, Gen Counsel & Sec) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| KELLERMAN DONALD J (SVP,Clinical Dev & Med Affairs) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 3,795 shares
@ $25, valued at
$94.9k
Disposed/sold 61,450 options to buy
@ $9.2, valued at
$565.3k
Disposed/sold 29,500 options to buy
@ $10.37, valued at
$305.9k
Disposed/sold 55,000 options to buy
@ $16.19, valued at
$890.5k
Disposed/sold 27,500 options to buy
@ $16.15, valued at
$444.1k
Disposed/sold 32,500 options to buy
@ $14.09, valued at
$457.9k
Disposed/sold 4,500 restricted stock units
@ $0
Disposed/sold 8,250 restricted stock units
@ $0 |
|
| 03/04/2013 |
4
| Borland Scott (SVP, Neurology Franchise) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| Wolff Henry Ward (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $12.74, valued at
$382.2k
Disposed/sold 7,500 options to buy
@ $3.18, valued at
$23.9k
Disposed/sold 7,500 options to buy
@ $14.77, valued at
$110.8k
Disposed/sold 7,500 options to buy
@ $16.47, valued at
$123.5k
Disposed/sold 10,000 options to buy
@ $11.69, valued at
$116.9k
|
|
| 03/04/2013 |
4
| WARD SCOTT R (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| OSHEA WILLIAM J (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $13.79, valued at
$275.8k
|
|
| 03/04/2013 |
4
| HENWOOD GERALDINE (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| HENWOOD GERALDINE (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/25/2013 |
4
| ARMER THOMAS A (Chief Scientific Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/25/2013 |
4
| GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/25/2013 |
4
| NELSON TIMOTHY S (President and CEO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 11/27/2012 |
4
| HENWOOD GERALDINE (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 06/08/2012 |
4
| Borland Scott (SVP, Neurology Franchise) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 05/21/2012 |
4
| Wolff Henry Ward (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $11.69, valued at
$116.9k
|
|
| 05/21/2012 |
4
| WARD SCOTT R (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options to buy
@ $11.69, valued at
$116.9k
|
|
| 05/21/2012 |
4
| HENWOOD GERALDINE (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 05/21/2012 |
4
| KELLEY BERNARD J (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 02/22/2012 |
4
| GIANAKAKOS ANASTASIOS (SVP & Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/27/2012 |
4
| ARMER THOMAS A (Chief Scientific Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/27/2012 |
4
| KELLERMAN DONALD J (SVP,Clinical Dev & Med Affairs) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 943 shares
@ $13.84, valued at
$13.1k
Granted 32,500 options to buy
@ $14.09, valued at
$457.9k
Granted 11,000 restricted stock units
@ $0
Exercised 2,250 restricted stock units
@ $0 |
|
| 01/27/2012 |
4
| GIANAKAKOS ANASTASIOS (SVP & Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/27/2012 |
4
| NELSON TIMOTHY S (President and CEO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/27/2012 |
4
| Borland Scott (SVP, Neurology Franchise) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/27/2012 |
4
| CHAI CHRISTOPHER Y (SVP & CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/27/2012 |
4
| Friedman Charlene A (SVP President, Gen Counsel&Sec) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/20/2012 |
4
| GIANAKAKOS ANASTASIOS (SVP & Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 01/17/2012 |
4
| OSHEA WILLIAM J (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $13.79, valued at
$275.8k
|
|
|
|
|